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Abstract Anions such as Cl− and HCO3
− are well known to
play an important role in glucose-stimulated insulin secretion
(GSIS). In this study, we demonstrate that glucose-induced Cl−
efflux fromβ-cells ismediated by the Ca2+-activatedCl− channel
anoctamin 1 (Ano1). Ano1 expression in rat β-cells is demon-
strated by reverse transcriptase–polymerase chain reaction, west-
ern blotting, and immunohistochemistry. Typical Ano1 currents
are observed in whole-cell and inside-out patches in the presence
of intracellular Ca++: at 1 μM, the Cl− current is outwardly rec-
tifying, and at 2 μM, it becomes almost linear. The relative per-
meabilities of monovalent anions are NO3
− (1.83±0.10) > Br−
(1.42±0.07) > Cl− (1.0). A linear single-channel current–voltage
relationship shows a conductance of 8.37 pS. These currents are
nearly abolished by blocking Ano1 antibodies or by the inhibi-
tors 2-(5-ethyl-4-hydroxy-6-methylpyrimidin-2-ylthio)-N-(4-(4-
methoxyphenyl)thiazol-2-yl)acetamide (T-AO1) and tannic acid
(TA). These inhibitors induce a strong decrease of 16.7-mM
glucose-stimulated action potential rate (at least 87 % on dis-
persed cells) and a partial membrane repolarization with T-
AO1. They abolish or strongly inhibit the GSIS increment at
8.3mM and at 16.7mMglucose. BlockingAno1 antibodies also
abolish the 16.7-mMGSIS increment. Combined treatment with
bumetanide and acetazolamide in low Cl− and HCO3
− media
provokes a 65 % reduction in action potential (AP) amplitude
and a 15-mVAP peak repolarization. Although the mechanism
triggering Ano1 opening remains to be established, the present
data demonstrate that Ano1 is required to sustain glucose-
stimulated membrane potential oscillations and insulin secretion.
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Introduction
Theβ-cell is known to be an excitable cell formore than 40 years
[15–17]. Glucose induces cyclic variations in the membrane
potential which are critical for sustained insulin release. Yet,
these variations cannot be all ascribed to the specific gating of
well-defined ion channels unlike what is established for the
membrane potential cyclic variations in the heart [4], as reflected
in electrocardiogram. Insulin release requires an increase of the
cytosolic calcium concentration ([Ca2+]i) by any means, i.e., ei-
ther from the extracellular medium or from intracellular stores.
When extracellular glucose concentration is raised (6–10 mM),
[Ca2+]i increase mainly results from the opening of the plasma
membrane L-type Ca2+ channels which appears as bursts of
spikes superimposed on repetitive slow waves of depolarization,
also called active phase. When glucose concentration is further
raised, the active phase is progressively extended and finally
appears uninterrupted at 25-mM stimulation [56, 81]. The earli-
est electrical event induced by glucose stimulation is the closure
of the K+ATP channel that induces membrane depolarization, the
latter being reproduced by sulfonylurea drugs [28]. Glucose and
sulfonylurea drugs induce long-term fluctuations of the mem-
brane potential with a spiking activity as soon as the threshold
of the L-type Ca2+ channels is reached, hence increase
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intracellular Ca2+ and insulin release which lasts as long as the
stimulus is applied (at least for 1 h) [29, 44, 51, 52, 62]. In sharp
contrast, depolarization induced by raising the external potassi-
um concentration results in a single sustained change in mem-
brane potential (and [Ca2+]i) which induces only a short burst
(±7 min) of insulin release, i.e., the so-called Bfirst phase^ of
insulin secretion with progressive decrease toward basal insulin
release [6, 32, 51, 52].
It is however well recognized that closure of K+ATP channels
alone is not sufficient to reach the threshold of Ca2+ channel
activation. As β-cells are quite rich in Cl− [9, 26], as early as
1978, Sehlin [66] questioned whether this depolarization could
be caused by a Cl− efflux as he demonstrated that glucose
induces an increase in 36Cl− efflux from 36Cl− prelabeled mice
islets. Also, severe reduction in anion efflux by incubation in
low Cl− (or bicarbonate) media inhibited the electrical bursting
pattern together with the 45Ca2+ uptake, hence the glucose-
stimulated insulin secretion (GSIS) [65, 67]. Furthermore,
Malaisse et al. [43] established that raising extracellular glucose
concentration in the range of 5–20 mM increased proportional-
ly the 36Cl− efflux from prelabeled rat islets, thus suggesting
that glucose induces the opening of some anion channel [43]. In
the present study, we therefore investigated whether such chlo-
ride efflux could be mediated by anoctamin 1 (Ano1) channel,
also called TMEM16A. Ano1 is a Ca2+-activated Cl− channel
(CaCC) which belongs to the Banoctamin^ family of anion
channels recently discovered and cloned (for review, see
Pedemonte and Galietta [55] and Kunzelmann [38]). This
new family of Cl− channel which shares no sequence similarity
with any other membrane protein appears expressed in almost
every tissue. In particular, Ano1 is expressed in many different
secretory epithelia including the digestive tract: salivary glands,
exocrine pancreas, hepatocytes, ileum, and large intestine. It
also plays a major role in the pacemaker motility function of
the interstitial cells of Cajal [35, 79]. Furthermore, it has also
been implicated in cell migration and cancer proliferation [75].
Ano1 knockout mice die soon after birth due to tracheomalacia
and also multiple organ impairment [63].
In support to our hypothesis implicating Ano1 in the depo-
larization critical to open Ca2+ channels, Ano1 haplo-
insufficient mice exhibit impaired insulin secretion [76], and
the present study provides evidence that the opening of the
calcium-sensitive Ano1 channel plays a prominent role in
glucose-inducedmembrane potential fluctuations and is there-
fore critical to achieve a sustained insulin secretion.
Materials
Chemicals
Ano1 (TMEM16A) inhibitors T16Ainh-AO1 or 2-(5-ethyl-4-
hyd roxy -6 -me thy lpy r im id in -2 -y l t h i o ) -N - ( 4 - ( 4 -
methoxyphenyl)thiazol-2-yl)acetamide (T-AO1) and tannic acid
(TA) were respectively purchased from Merck Biosciences
(Darmstadt, Germany) and Sigma (St Louis, MO, USA). Bu-
metanide (NKCC1/2 inhibitor, #B-3023), acetazolamide (car-
bonic anhydrase inhibitor, #A-6011), and poly-L-lysine
hydrobromide (#P6282) were purchased from Sigma (St Louis,
MO, USA). Compounds of the different buffers were purchased
fromMerck (Darmstadt, Germany). Collagenase P (#11 213 873
001) and protease inhibitors (complete mini #11 836 153 001)
were purchased from Roche (Mannheim, Germany).
Antibodies
Rabbit polyclonal Ano1 antibodies (ab84115) for western
blotting purpose, rabbit polyclonal blocking Ano1 antibodies
(ab72984, directed against the fifth and sixth transmembrane
domains that constitute the pore-forming region) for patch-
clamp and insulin release experiments, and human Ano1 syn-
thetic peptide (ab97423) for immunofluorescence purpose
were purchased from Abcam (Cambridge, UK). Goat poly-
clonal Ano1 antibodies (sc-69343) for immunofluorescence
purpose were purchased from Santa Cruz Biotechnology
(Dallas, TX, USA). Rabbit anti-goat biotinylated antibody
(BA-5000) was purchased from Vector Laboratories (Peter-
borough, United Kingdom). Horseradish peroxidase (HRP)-
conjugated anti-rabbit was purchased from Dako (Glostrup,
Denmark).
Tissue culture and tissue samples
Tissue culture materials were purchased from Sarstedt
(Nümbrecht, Germany). Culture media were purchased from
Invitrogen Life Technologies (Carlsbad, CA, USA). Experi-
ments were carried out on murine pancreatic islets or dis-
persed β-cells from Wistar rat and C57BL/6 mice. Animals
were anesthetized with Nembutal before decapitation. All ex-
perimental procedures were conducted in agreement with the
protocol approved by the Ethical and Animal Welfare Com-
mittee of the Université Libre de Bruxelles (protocol number
375N). Human cadaveric islet total RNAwas kindly provided
by Dr Ramon Gomis from the Barcelona Hospital Clinic.
Approval of the experimental use of the islets was granted
by the Barcelona Hospital ethics committee, and informed
consent was given by the donors’ families.
Methods
Preparation of rat and mouse pancreatic islets
Pancreatic islets were isolated by collagenase technique [42].
Bile duct was clamped at its entrance in the duodenum, and a
cannula was inserted to inject 15-ml Hank’s-glucose solution
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containing 5.8 mg collagenase P by rat or 2-ml Hank’s–glu-
cose solution containing 4 mg collagenase P by mouse, in
order to distend the pancreas and digest the exocrine gland.
Hank’s–glucose solution contained the following (in mM):
137 NaCl, 5.4 KCl, 1.2 CaCl2, 0.8 MgSO4, 0.3 Na2HPO4,
0.4 KH2PO4, 4.2 NaHCO3, and 11.1 glucose, pH 7.4. The
inflated pancreas was extracted and incubated for 15 min
(rat) or 9 min (mouse) at 37 °C in a 50-ml conical tube. Di-
gestion was then stopped by addition of 20-ml ice cold
Hank’s–glucose solution. The suspension was first gently ag-
itated for 1 min and then vigorously for few seconds. The
preparation was transferred in a crystallizing dish before three
successive dilution–resuspension–sedimentation–aspiration
cycles with 60-ml ice cold Hank’s–glucose solution in order
to remove collagenase and floating exocrine acini. Islets were
individually collected under a microscope using a pipette and
laid at room temperature, on a Petri dish with 4-ml culture
medium containing 5 mM glucose (RPMI #21875-034
GIBCO containing 11.1 mM glucose diluted with RPMI
#11879-020 GIBCO glucose-free, 10 % heat inactivated fetal
bovine serum #10500-064 GIBCO, 50 IU/ml penicillin,
50 μg/ml streptomycin #15070-063 GIBCO). This last step
was repeated three to four times to wash islets. Four hundred
to six hundred pancreatic islets were obtained from one single
rat pancreas, while 20 to 100 islets were isolated from one
mouse. The Petri dish containing the islets was then placed
at 37 °C in a humidified incubator gassed with 5 % CO2 in air.
Each preparation was obtained by pooling islets from two
animals. The islets were immediately used for experiments.
Preparation of dispersed rat or mouse islet cells
Freshly isolated pancreatic islets from two animals were
suspended in a 1.5-ml tube. The culture medium was
discarded and replaced by a 0.5-ml isotonic 0.05 % tryp-
sin–EDTA solution (#25300-054 GIBCO) before incuba-
tion at 37 °C, in a humidified incubator gassed with
5 % CO2 in air for 9 min. After incubation, the trypsin–
EDTA solution was replaced by 0.62-ml culture medium
containing 11.1 mM glucose and cells were separated by
tenfold gentle suction-pushing with a pipette. Thirty-five to
50 μl of cell suspension was laid onto 1.0-cm-diameter
glass poly-L-lysine (PLL)-precoated coverslips (Merck,
Darmstadt, Germany). The coating procedure consisted to
bath the coverslips for 5 min in a 0.1 or 0.3 mg/ml PLL
solution in sterile Milli-Q water before successively rinsing
again in sterile Milli-Q water and drying overnight at
room temperature in six-well plates. Afterward, cells were
placed at 37 °C in a humidified incubator gassed with
5 % CO2 in air for 30 min to promote adherence before
gentle addition of 4-ml culture medium containing 5 mM
glucose. Finally, cells were stored overnight in the incuba-
tor before experiments.
Insulin release
Groups of eight rat pancreatic islets were placed in 1.5- or 2-
ml assay tubes. Islets were first preincubated for 30 min in 1-
ml Hepes-buffered NaCl solution without bicarbonate or in
Hepes and bicarbonate-buffered NaCl solution both supple-
mented with 1 or 5 mg/ml bovine serum albumin (BSA) and
2.8 mM glucose in presence (or not) of T-AO1, TA, DMSO,
rabbit blocking Ano1 antibodies (ab72984, Abcam), or rabbit
whole serum and next incubated for 90 min in the same me-
dium at various glucose concentrations: 2.8, 8.3, and
16.7 mM. Hepes-buffered NaCl solution without bicarbonate
contained the following (in mM): 140 NaCl, 10 Hepes, 4 KCl,
1 MgCl2, and 1 CaCl2, pH 7.3, with NaOH. Hepes and
bicarbonate-buffered NaCl solution contained the following
(in mM): 111 NaCl, 10 Hepes, 5 KCl, 1 MgCl2, 1 CaCl2,
and 24 NaHCO3, pH 7.4, with NaOH. After 90 min, 0.2- or
0.5-ml incubation medium was collected. Sampled incubation
media were frozen for insulin content determination. Experi-
ments were performed at 37 °C. In presence of bicarbonate
media, preincubation and incubation were performed in a hu-
midified incubator gassed with 5 % CO2 in air. Insulin content
of each sample was measured by radio immmunoassay tech-
nique [40] or by ELISA (#10-1250-10 Insulin, rat ELISA,
Mercodia, Uppsala, Sweden).
Patch-clamp experiments
Mouse islets were immobilized at the end of a negatively
pressured large borosilicate glass pipette, in the patch-clamp
chamber using a micromanipulator (Prior, England). Whole
islets were blind-patched between day 0 and day +2. These
experiments were carried out on mouse islets, as the sealing
could not be maintained for prolonged periods with β-cell
fromwhole rat islet. Dispersed rat or mouse islet cells cultured
onto poly-L-lysine-precoated glass coverslips were used be-
tween day +1 and day +3. β-Cells (representing 80–90 % of
the cells) were visually identified by their large size and their
granular appearance [8]. Islets or coverslips were placed in the
patch-clamp chamber and continuously perfused (1 ml/min).
The temperature in the chamber was maintained at 34 °C with
a homemade heater (gift from Prof D. Gall, Department of
Biophysics, ULB, Belgium). The patch pipettes were
double-step pulled from borosilicate glass capillaries
(Hilgenberg GmbH,Malsfeld, Germany) using a vertical pull-
er (PC-10, Narishige International, London, UK). Liquid junc-
tion potentials were balanced after formation of a gigaseal
contact. Voltages and currents were monitored with a PC-
501A amplifier (Warner Instruments, Hamden, CT, USA) or
an Axopatch 200A (Axon instruments, Inc., Foster City, CA,
USA). Zero-current whole-cell voltages and currents were
continuously recorded using WinEDR or WinWCP software
(John Dempster, Strathclyde Institute of Pharmacy and
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Biomedical Sciences, UK). β-Cells were functionally identi-
fied by the presence of action potential (AP) bursts induced by
stimulating glucose concentration.
Voltage measurements
Nystatin-perforated whole-cell configuration patch-clamp ex-
periments were conducted as previously described [70]. Bath
solution was a Hepes-buffered NaCl solution without bicar-
bonate (see BInsulin release^ section) supplemented with 2.8
or 16.7 mM D-glucose or low chloride (20 mM) by replace-
ment of 140 mMNaCl in Hepes-buffered NaCl solution with-
out bicarbonate by 12 mM NaCl and 128 mM Na-gluconate,
osmolarity 311 or 325 mOsmol/l. Pipette solution contained
the following (in mM): 10 NaCl, 20 KCl, 75 K2SO4, and 10
Hepes, pH 7.2, with KOH, supplemented with 50 to
300 μg/ml nystatin, osmolarity 299 mOsmol/l. Stock solution
of nystatin (10 to 30 mg/ml in DMSO) was daily prepared.
Filled pipettes had resistances of 6–10 MΩ. Whole-cell con-
figuration induced by nystatin permeabilization was achieved
within 10 to 15 min. Leak resistance after sealing was usually
at least 3 GΩ. Access resistance (Rs) was <35MΩ. Cells were
stored in incubator and used within 60-min incubation. The
effects of T-AO1 or TA on islets were evaluated during active
phase after 5-min exposure for at least 3 min or more (30–
40 min). APs were counted for 3 min during active phase,
1 min at the beginning, 1 in the center, and 1 at the end. On
dispersed cells, the effect of 16.7 mM glucose was evaluated
during the spiking activity for at least 30 s or more (1–2 min).
The effects of T-AO1 and TA on the potential and APs were
evaluated after 1- or 2-min exposure for at least 1 min or more
(3–6 min). In low-chloride solution in presence of 200 μM
bumetanide, the initial effect of glucose (Ini) was evaluated
during 20 to 60 s at the beginning of the spiking activity before
the rundown of AP peak. Its effect in presence of bumetanide
was also evaluated after 5-min glucose stimulation for a period
of at least 5 min (G + 5 min). The effect of 5 mM acetazol-
amide on glucose and bumetanide was further evaluated after
5-min acetazolamide incubation and for a period of at least
5 min (Acet + 5 min).
Chloride current measurements
Chloride currents from rat dispersedβ-cells weremeasured on
inside-out single excised patches and whole cell. Filled pipette
resistance was 5 MΩ (Fig. 5) except for single-channel cur-
rents, 20 MΩ (Fig. 6). Sealing was first performed in Hepes-
buffered NaCl solution without bicarbonate containing
2.8 mM glucose (see BInsulin release^ section). On inside-
out single excised patches (macropatches, filled pipette resis-
tance 5 MΩ, Fig. 5), the bathing solution was replaced after
sealing by 150 mM N-methyl D-glucamine chloride (NMDG-
Cl), pH 7.3, solution containing CaCl2 at the indicated
concentration (0 to 2 μM), which flowed during 90 s before
excision. After excision, leak resistance was 7–25 GΩ. Mea-
surements were performed after 2-min exposure of the cyto-
plasmic side of the patch to bath solution. Pipette solution
contained also 150 mM NMDG-Cl, pH 7.3, in presence or
absence of 10 μM T-AO1, active blocking Ano1 antibodies
ab72984 1:100 or boiled (heated at 99 °C for 10min) blocking
Ano1 antibodies ab72984 1:100. In the experiments with T-
AO1 or antibodies, sealing was performed 5 min before mea-
surements so that a 5-min preincubation occurred. Current
traces recorded (sampling rate, 25 kHz; 2-kHz filter setting)
were induced by 1500-ms voltage steps from −100 to +
100 mV, spaced 20 mV (holding potential, −70 mV, 200 ms
before and after each step). Steady-state current–voltage rela-
tionship was constructed from the average Cl− currents mea-
sured between ms 1400 and 1500 of voltage stimulation. In
voltage step experiments, the stability of Cl− currents at the
holding potential (−70 mV) before the 11 voltage steps was
indicative of the stability of [Ca2+]i and of the absence of
apparition of sudden leakage currents. Single-channel Cl− cur-
rents were also measured on inside-out excised patches (filled
pipette resistance 20 MΩ, Fig. 6). After sealing, the bathing
medium was replaced just before excision, by a 150 mM
NMDG-Cl, pH 7.3, calcium-free medium. Stimulation of
CaCC was performed with the same medium containing
1 μM CaCl2. Pipette solution was 150 mM NMDG-Cl, pH
7.3, supplemented with 10 μM glibenclamide and 10 μM ni-
fedipine and contained (or not) 100 μM T-AO1 or TA. Cur-
rents were corrected for leakage. Leak resistance after sealing
was usually 7 to 15GΩ. Single-channel records were analyzed
using pCLAMP software where all event lists of single-
channel records were generated by Fetchan program (Molec-
ular Devices, Sunnyvale, CA). NPo, the product of the num-
ber of channels in a patch (N) by the open probability (Po),
which reflects the channel activity within a patch, was calcu-





where T is the total recording time, i is the number of open
channels, ti is the recording time during which i channels were
open, and N is the apparent number of channels within the
determined patch (as the highest observable level). Therefore,
NPo can be calculated without making any assumption about
the total number of channels in a patch or the open probability
of single channels. AllNPo values were calculated for 120 s of
recording after 15-s stimulation with 1 μM Ca2+. To meet the
electrophysiological convention, inward Cl− currents from
inside-out patches (pipette to cell) were represented as upward
transitions. In whole-cell experiments, pipette solution was
150 mM NMDG-Cl, pH 7.2, containing 0 or 1 μM CaCl2,
in presence or absence of blocking Ano1 antibodies ab72984
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1:100 or boiled blocking Ano1 antibodies ab72984 1:100 (cy-
tosolic side of the cell). After sealing, the bathing solution was
replaced by 150 mM NMDG-Cl, pH 7.3. The membrane was
ruptured by suction to form a whole cell. Access resistance
was about 10 MΩ. Series resistance was 50 % compensated.
Leak resistance was 7–25 GΩ. Measurements were performed
6 min after whole-cell formation or from 6 to 12 min with
blocking Ano1 antibodies. In the experiments with T-AO1,
the bathing solution was replaced 2 min before measurements
by 150 mM NMDG-Cl, pH 7.3, containing 10 μM T-AO1
which was thus preincubated for 2 min externally. Current
traces recorded (sampling rate, 10 kHz; 2-kHz filter setting)
were induced by 400-ms voltage steps from −100 to +100mV,
spaced 20 mV (holding potential, −70 mV, 100 ms before and
after each step). Current–voltage relationship was constructed
from the average Cl− currents measured between ms 380 and
400 of voltage stimulation. In monovalent anion permeability
experiments (also whole-cell experiments), an agar-KCl 3M
salt bridge provided the junction between the Ag/AgCl refer-
ence electrode and the bath. Pipette solution was 150 mM
NMDG-Cl, pH 7.2, containing 1 μM CaCl2. The bathing so-
lution (150 mM NMDG-Cl) was replaced by 150 mM
NMDG-NO3 or NMDG-Br, pH 7.3, which flowed during
1.5 min before a first measurement performed 6 min after
whole-cell formation. The bathing solution was then ex-
changed with 150 mMNMDG-Cl for 1.5 min before a second
measurement. Current traces recorded (sampling rate, 25 kHz;
2-kHz filter setting) were induced by a slow voltage ramp:
from holding potential (−70 mV, 200 ms), a step to
−100 mV, 400 ms was applied followed by a 10-s linear volt-
age ramp from −100 to +100 mV with thereafter a step to
holding potential, −70 mV, 200 ms. Parts of ramps from −40
to +40 mVare represented in Fig. 5j, l.
Barium current measurements
In whole-cell experiments, cells were first immersed in Hepes-
buffered NaCl medium containing 2.8 mM glucose (see
BInsulin release^ section). After establishing the whole-cell
configuration, the medium was then replaced by a barium
solution containing (in mM) 75 BaCl2, 10 Hepes, 35
NMDG-gluconate, pH 7.3, with NMDG, osmolarity
310 mOsm/l and supplemented (or not) with 100 μM Ano1
inhibitors (T-AO1 or TA) or 10 μM nifedipine. Pipette solu-
tion contained (in mM) 103 NMDG-Cl, 10 Hepes, 3 MgATP,
43 NMDG-gluconate, 10−4 CaGluconate2, pH 7.15 with
NMDG, osmolarity 310 mOsm/l. Chloride equilibrium poten-
tial was −10mV. Holding potential was −70mV. Filled pipette
resistance was 5 MΩ. Leak resistance was at least 3 GΩ (usu-
ally 4 to 7 GΩ) after establishment of the sealing. Access
resistance (Rs) was between 10 and 20MΩ. The currents have
been corrected for leakage and capacity currents. Series resis-
tance was compensated by 50 %. Ba2+currents were observed
during 200-ms depolarizations to −10 mV from a holding
potential of −70 mV in the absence or presence of T-AO1
(100 μM), TA (100 μM), or nifedipine (10 μM) in the bathing
medium and normalized (or not) to the capacitance of each
cell. To establish the peak inward current (I)–voltage(V) rela-
tionship, 25-ms depolarizations from −50 to + 30 mV by 10-
mV voltage steps were applied from a holding potential of
−70 mV. Only the first set of measurements was considered
for each cell to avoid a rundown of the currents.
Reverse transcriptase for Ano1
Total RNA from rat and human tissues (pancreas, kidney) was
extracted using the AURUM™ total RNA fatty acid and tissue
kit (Bio-Rad, Hercules, CA, USA), and then, complementary
DNA (cDNA) was prepared using the High-Capacity cDNA
Reverse Transcription kit (Applied Biosystems, Waltham,
MA, USA). RT-PCR reactions were carried out in 20-μl final
volume containing the following: 1 μl of cDNA added to 4 μl
of Go Taq Green 5× Buffer, 0.2 mM dNTP, 0.5 μM of each
primer, and 0.5 U Go Taq™ polymerase (Promega, Madison,
WI) using MyCycler™ Thermal Cycler (Bio-Rad Laborato-
ries, Hercules, USA). Primers used (GenBank accession no.
NM_001107564) for rat Ano1 were as follows: forward 5′-
GCAGGCCTGGAGCTGGAACG-3 ′and reverse 5 ′-
GCTCAGCCACCTTGGGCTGG-3′, and those (GenBank
no. NM_018043) for human Ano1: forward 5 ′ -
CACAGGCGGCCACGATGAGG-3 ′ and reverse 5 ′-
GGGGTGGTCCTGCTTGACGC-3′. Thermocycler condi-
tions were:denaturation at 95 °C for 90 s followed by 35 cycles
(95 °C for 30 s, 60 °C for 30 s, 72 °C for 1 min) and finished by
a final elongation at 72 °C of 5 min. Amplicons were separated
on a 1.2 % agarose gel in TAE buffer (40 mM Tris base,
20 mM acetic acid, 1 mM EDTA, pH 7.4, supplemented with
0.5 μg/ml ethidium bromide). Gels were visualized by UV
translumination, using a GelDoc apparatus (Fusion FX5 Vilber
Lourmat). A sequence analysis was performed on purified
PCR products: 5 μl of PCR products was treated with
ExoSAP-IT enzyme (Affymetrix Santa Clara, CA, USA) in
order to remove excess dNTPs and residual primers. The reac-
tionwas carried out at 37 °C for 15 min and stopped by heating
at 80 °C for 15 min. Two microliters of the mix PCR/ExoSAP-
ITwas mixed with 2 μl Ano1 primers 3.5 pmol/μl, and volume
was finally completed to 7 μl with water. Sequencing was
subcontracted to external services (Beckman coulter genomics,
Danvers, MA, USA), and the sequences were compared using
nucleotide BLAST search program (BLAST2SEQ) of NCBI
database. (http://www.ncbi.nlm.nih.gov).
Immunodetection analysis of Ano1 in rat islets
Immunodetection of Ano1 was performed by Western blot-
ting. Islets were isolated, as previously described, from two
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rats and lysed into 60 μl ice cold RIPA lysis buffer (50 mM
Tris base, pH 7.4, 150 mM NaCl, 1 % NP-40, 0.25 % sodium
desoxycholate, and supplemented with Roche protease
inhibitor tablet). Protein concentration, measured by
Bradford, was 4 μg/μl. After centrifugation (16,000
rcf, 15 min), samples were supplemented with Laemmli
buffer/1 % dithiothreitol (Laemmli 4×: 250 mM Tris–
HCl, pH 6.8, 40 % glycerol, 5 % SDS, bromophenol
blue; sample: Laemmli buffer 4×, 3 v:1 v) and dena-
tured by heating at 70 °C for 30 min. Proteins were
separated on a 5 % acrylamide gel and transferred to
a PVDF membrane. Procedure was as previously de-
scribed [45]. After blocking, the membrane was succes-
sively incubated overnight at 4 °C with a rabbit poly-
clonal anti-ANO1 (ab84115, Abcam) 1:1000, rinsed, and
incubated at room temperature for 2 h with HRP-
conjugated anti-rabbit. Detection was performed by ex-
posure to enhanced chemiluminescence (Amersham).
Human thyroid extract was used as positive control.
Molecular weight of rat Ano1 was estimated at
119 kDa, from Rattus norvegicus peptide sequence
(NP_001101034.1, NCBI).
Immunofluorescence detection of Ano1 in rat pancreas
sections
Pancreas was quickly dissected and further fixed by over-
night immersion in 4 % (w/v) paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4. The tissue was then transferred to
successive graded sucrose solutions (10, 20, and 30 %,
overnight each) and finally embedded in Tissue-Tek
OCT™ compound (Sakura Finetek Europe, Leiden, the
Netherlands), snap-frozen in cold 2-methylbutane, and
stored at −80 °C. Cryosections (10 μm) were cut on a
cryostat (Leitz, Iena, Germany), mounted on glass slides
(International Medical Products, Brussels, Belgium), coated
with 0.1 % poly-L-lysine, and stored at −20 °C until use.
Before the immunostaining immunofluorescence procedure,
the slides were submitted to an epitope unmasking proce-
dure: the slides were immerged in a 0.01 M citrate buffer,
pH 6, and boiled in a microwave oven for 10 min
(2450 MHz, 850 W). The slides remained in the plastic
jars for 15 min until cooling to room temperature, were
then washed with a Tris-buffered saline solution (TBS,
composition in mM: 50 Tris–HCl, 110 NaCl, pH 7.5) and
dropped for 30 min in methanol containing 0.3 % hydrogen
peroxide in order to block endogenous peroxidase activity.
Slides were quickly washed in water, preincubated for
60 min in TBS supplemented with normal rabbit serum
(NRS) 1:10, and incubated overnight at room temperature
with either goat polyclonal anti-Ano1 sc-69343 (Santa-
Cruz) 1:50 or for specificity control in a mix of anti-
Ano1 sc-69343:Ano1 peptide ab97423 (Abcam) in ratio
of 1:8 preincubated for 2 h in TBS containing NRS
1:100. The slides were washed in TBS and incubated for
30 min with a secondary rabbit anti-goat biotinylated anti-
body BA-5000 (Vector Laboratories) 1:300, rinsed in TBS,
and incubated for 1 h with a streptavidin–peroxidase com-
plex. The slides were washed again in TBS and incubated
for 10 min with Tyramide Alexa Fluor 488 1:100 in the
amplification buffer provided in the kit (T-20932, Thermo
Fisher Scientific, Waltham, MA, USA). Finally, after rins-
ing twice in TBS, the cryostat slides were washed in water
and mounted using Glycergel (Dako, Glostrup, Denmark)
supplemented with 2.0 % of the antifading compound 1,4-
diazobicyclo[2.2.2]octane (DABCO, Sigma, St Louis, MO,
USA). Sections were examined with a Zeiss Axioplan mi-
croscope, and images were acquired using an AxioCam
HRc camera. After the images were captured, a
counterstaining of the same slides with hematoxylin and
eosin confirmed the localization of the immunofluorescence
signal at the level of the pancreatic islets.
Statistics
Results are presented asmean values (±SEM)with the number
of individual experiments (n) except for Fig. 6c where all the
points are showed. The normality of population distributions
was assessed by Shapiro–Wilk tests. Datasets with normal
distributions were compared using parametric tests. Datasets
containing at least a non-normal distribution were compared
using nonparametric tests. Statistic tests were performed using
SPSS 22 software (IBM, Armonk, NY).
Results
Expression of Ano1 in rat pancreatic islets
By RT-PCR, the transcript of Ano1 was found in total pan-
creas and in purified islet preparation in both rat and human
species. As kidney is well known to express Ano1 [23],
messenger RNA (mRNA) extracted from kidney was used
as positive control (Fig. 1a). The comparison of sequences
of PCR products obtained by amplification of rat total pan-
creas, isolated islets, and kidney cDNAs vs. reference se-
quences was performed using BLAST2SEQ program (acces-
sion number: NM_001107564.1) and confirmed 100 %
identity. The expression of Ano1 protein in whole rat islets
was assessed by western blotting (80 and 30 μg prot/lane)
using a human thyroid lysate as positive control. This clearly
established that Ano1 is expressed in rat islet cells, as ob-
served in human and mice β-cells [27]. Ano1 cellular dis-
tribution was further studied in the pancreas by immunoflu-
orescence. A strong Ano1 staining was observed at the level
of Langerhans’ islet and in acinar cells at the apical side of
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the acini (Fig. 1c). Almost all the cells of the islet were
labeled (Fig. 1 (c1)) as confirmed by the hematoxylin–eosin
counterstaining (Fig. 1 (c2)) which was performed on the
same slice. Coincubation of the primary goat Ano1 antibodies
with Ano1 synthetic peptide (which competes with tissue Ano1)
in a ratio 1:8 completely prevented the labeling (Fig. 1 (c3)).
Effect of Ano1 on GSIS in rat pancreatic islets
In Hepes-buffered NaCl solution without bicarbonate
(Fig. 2a), 8.3 and 16.7 mM GSIS, respectively, represented
263.2±33.9 (n=58, P=2.79×10−12) and 404.2±48.5 % (n=
59, P<10−13) of the basal secretion (n=58). When incubated
with 8.3 mM glucose, T-AO1 and TA 100 μM completely
prevented the insulin output increase (T-AO1: n=30, P=
3.40×10−13 vs. 8.3 mM glucose, P=0.878 vs. 2.8 mM glu-
cose and TA: n=29, P=1.30×10−7 vs. 8.3 mM glucose,
P>0.999 vs. 2.8 mM glucose). In presence of 16.7 mM glu-
cose, T-AO1 also abolished the relative increment in insulin
output (n=30, P<10−13 vs. 16.7 mM glucose, P>0.999 vs.
2.8 mM glucose), while TA reduced it to 32.6±10.6 % (n=29,
P=6.39×10−13 vs. 16.7 mM glucose, P=0.00292 vs. 2.8 mM
glucose). GSIS (16,7 mM) in the absence of bicarbonate
(Fig. 2a) represented 39.3±4.3 % of the insulin release mea-
sured in 24-mM bicarbonate medium (Fig. 2b, P=1.16×10−19
by independent Student’s t test), in agreement with the obser-
vation reported by Henquin and Lambert [29]. In bicarbonate
medium, 16.7 mMGSIS represented 905.7±218.5 % of basal
secretion (Fig. 2b, n=20, P<0.001 vs. 2.8 mM glucose). T-
AO1 dose-dependently decreased 16.7mMGSIS (Fig. 2b, n=
19–32). No significant inhibitory effect was observed for T-
AO1 concentrations up to 30 μM (3 μM, P>0.999; 10 μM,
P>0.999; 30 μM, P=0.371 vs. 16.7 mM glucose) although
the 16.7-mM GSIS increment in presence of 30 μM T-AO1
represented only 58.1±13.5%. T-AO1100 μMprevented any
increase in GSIS (P<0.001 vs. 16.7mMglucose,P>0.999 vs.
2.8 mM glucose). The importance of Ano1 in GSIS was also
confirmed by the abolition of 16.7-mM GSIS increment by
the blocking Ano1 antibodies ab72984 [14] in bicarbonate
medium (Fig. 2c). The relative increment at 1:100 dilution
was 23.9±16.0 % (Fig. 2 (c3), n=9–12, P=0.036 vs.




















































Fig. 1 Detection of Ano1 in pancreas and pancreatic islets. a RT-PCR of
cDNA prepared from mRNA extracted from rat and human tissues.
Transcripts of the expected size for Ano1 are observed (rat: 223 bp;
human 314 bp). The 300-bp band is shown in the molecular weight
marker column (MWM). Positive control: kidney. Negative control
(Neg. control): no DNA. The sequencing of PCR products confirmed
100 % identity with the reference sequence for rat Ano1 cDNA
complementary of rat Ano1 mRNA. b Western blot of Ano1 in rat
islets, from left to right: molecular weight column (MW) showing the
100-, 150-, and 250-kDa bands, 80 μg rat islet lysate, 30 μg rat islet
lysate, and 30 μg human thyroid lysate (positive control). Ano1 is
detected at 119 kDa. c Immunofluorescence staining of pancreas section.
c1 Immunohistochemical labeling (green-fluorescent Tyramide Alexa
488) of Ano1 in a section photomicrograph of rat pancreas. Most of the
islet cells and acinar cells (at the level of apical pole) are labeled. c2
Counterstaining labeling by hematoxylin–eosin performed on the slice
used for c1. c3 Specificity control: immunohistochemical labeling of
Ano1 in a section photomicrograph of rat pancreas. The primary goat
Ano1 antibodies (sc-69343) were coincubated in the presence of Ano1
synthetic peptide (ab97423) in a ratio 1:8. The labeling disappears. c4
Counterstaining labeling by hematoxylin–eosin performed on the slice
used for c3. Arrows show islets. Scale bar is 50 μm
Pflugers Arch - Eur J Physiol (2016) 468:573–591 579
Effect of Ano1 inhibitors T-AO1 and TA on the membrane
potential of β-cell from whole mouse islet
Zero-current nystatin-perforated patch-clamp voltage record-
ings were performed on cells from intact islets stimulated with
16.7 mM glucose. After a first prolonged depolarization, a
cyclic pattern of membrane potential fluctuations was ob-
served with alternating depolarized active phases (slow waves
with bursts of spikes) and partially repolarized silent phases,
as previously reported [25, 30]. Figure 3a shows such a rep-
resentative membrane voltage recording in a cell stimulated
with 16.7 mM glucose.
The effects of T-AO1 and TA inhibitors (100 μM) were
evaluated after 5-min exposure. APs were counted for 3 min
during the active phase (1 min at the beginning, 1 in the mid-
dle, and 1 at the end). Representative membrane voltage re-
cordings in presence of T-AO1 or TA are presented in Fig. 3b,
g. The greatest impact of inhibitors occurred on AP rate: T-
AO1 largely reduced glucose-stimulated AP rate, averaging
4.74±0.58 s−1 to 1.17±0.86, i.e., by 78.7±14.1% (Fig. 3c, n=
3, P=6.30×10−3). A reduction from 4.91±0.62 to 3.32±
0.50 s−1, thus by 33.5±5.1 %, occurred with TA (Fig. 3h,
n=7, P=2.44×10−3). Ano1 inhibition with TA repolarized
also the AP peak that averaged −15.41±3.73 to −24.47±
3.03 mV, thus by 9.06±1.13 mV (Fig. 3i, n=9, P=4.18×
10−5), but T-AO1 repolarization from −18.71±1.58 to
−22.65±2.68 mV, i.e., by 3.94±1.41 mV, was not significant
(Fig. 3d, n=3). TA also provoked a significant reduction of
33.9±2.5 % of AP amplitude (39.09±4.40 mV in its absence
vs. 26.23±3.89 mV in its presence, Fig. 3i, n=9, P=3.00×
10−6), while T-AO1 did not (Fig. 3e, n=3), Glucose stimula-
tion depolarized the cell (resting potential −74.02±0.93 mV,
n=12), and during active phase, the plateau potential averaged
−53.42±1.34 mV (n=12, P=5.19×10−8). The inhibitors did
not repolarize the plateau potential: Fig. 3f (T-AO1) and
Fig. 3k (TA). The fraction of plateau phase (FOPP, relative
duration of the active phase) of 16.7 mM glucose-stimulated
β-cell with glucose approached a value of 60 % [56, 81]. In
presence of TA, the duration of both silent and active phases
was about threefold extended with almost no effect on FOPP
which barely decreased from 0.615±0.026 to 0.589±0.059
(n=6, P=0,733, paired t test).
Effect of Ano1 inhibition on the membrane potential
from rat and mice dispersed β-cells
Zero-current nystatin-perforated patch-clamp voltage record-
ings were performed on single dispersed β-cells stimulated
with glucose. Only cells showing a resting potential of −70±
8 mV were examined: 16.7 mM glucose induced a pattern of
electrical activity with numerous repetitive fast-spiking activ-
ity. The addition of T-AO1 or TA into the bathing medium is

































































































































Fig. 2 Insulin release from rat pancreatic islets is drastically reduced in
the presence of Ano1 inhibitors and blocking Ano1 antibodies. Islets
were first preincubated in 2.8 mM glucose, in the presence (or not) of
T-AO1, TA, or blocking Ano1 antibodies (ab72984), and then incubated
for 90min in the samemediumwith different glucose concentrations (2.8,
8.3, and 16.7 mM). The experiments were always performed on groups of
eight islets isolated from preparations of two rats. a Effect of T-AO1 and
TA (100 μM) on glucose-stimulated insulin secretion (GSIS) from rat
islets in Hepes-buffered NaCl solution without bicarbonate as used in
the patch-clamp voltage measurements (n=58–59 from six preparations
in conditions without inhibitors, n=29–30 from three preparations in
conditions with inhibitors). Preincubation with T-AO1 or TA
completely abolished the increment in insulin output on glucose 8.3-
mM stimulation. With 16.7 mM glucose, no increase was observed in
the presence of T-AO1, while the relative increase was weak with TA
(32.6±10.6 %). b Dose-dependent effect of T-AO1 on 16.7 mM GSIS
from rat islets in Hepes and bicarbonate-buffered NaCl solution (n=19–
20 from three preparations except for 10 μM T-AO1, n=32). T-AO1
100 μM prevented any increase in GSIS. c Effect of rabbit blocking
Ano1 antibodies ab72984 (in whole serum) on 16.7 mM GSIS from rat
islets in Hepes and bicarbonate-buffered NaCl solution. c1 No antibody/
no serum (n=20 from two preparations). c2 ab72984 or serum 1:250 and
c3 ab72984 or serum 1:100 (c2 and c3, n=9–12 from three preparations).
The relative increment in presence of 1:100 antibodies was reduced to
23.9±16.0 % with a secretion value not significantly different from
control (P=0.15 vs. 2.8 mM glucose). One-way ANOVA test on a, P=
1.41×10−46; Kruskal–Wallis test on b, c2, c3, P<0.001; Mann–Whitney
test on c1, P<0.001. *** P<0.001 vs. 2.8 mM glucose condition;
°P<0.05, °°°P<0.001 vs. 16.7 mM glucose-stimulated condition (Sidak
tests in a; Mann–Whitney-type tests with Dunn–Bonferroni correction in
b, c2, c3)
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Glucose depolarized rat β-cells from an average resting po-
tential of −70.43±1.00mV to an average potential of −36.12±
1.52 mV (n=15, P=3.99×10−11, paired t test). The main
modification in the oscillatory pattern in presence of the in-
hibitors occurred in AP. The AP rate was drastically reduced
from 4.35±0.84 to 0.50±0.24 s−1, i.e., by 90.3±3.3 % in
presence of T-AO1 (Fig. 4b, n=7, P=0.00128), or inhibited
by 100 % in presence of TA (Fig. 4e, n=8, P=2,19×10−4).
The average AP rate measured on the stimulated cells was
5.49±0.67 s−1 (n=15). T-AO1 partially repolarized the

















































































G 16.7 mMG 16.7 mM























































































Fig. 3 Effect of Ano1 inhibitors on the membrane potential of β-cell
from whole mice islet stimulated with 16.7 mM glucose. a, b, g
Representative zero-current nystatin-perforated patch-clamp voltage
recordings. Sampling rate, 18 kHz; 2-kHz filter setting. Dotted lines
represent zero-voltage level. a Glucose-stimulated cell (16.7 mM
glucose). b Glucose-stimulated cell±100 μM T-AO1 in the bathing
medium. c Effect of T-AO1 (n=3) on action potential (AP) rate, in
presence of glucose. d Effect of T-AO1 (n=3) on AP peak, in presence
of glucose. e Effect of T-AO1 (n=3) on AP amplitude, in presence of
glucose. f Effect of T-AO1 (n=3) on the membrane plateau potential
during active phase in presence of glucose. g Glucose-stimulated cell±
100 μM TA in the bathing medium. h Effect of TA (n=7) on action
potential rate, in presence of glucose. i Effect of TA (n=9) on AP peak,
in presence of glucose. j Effect of TA (n=9) onAP amplitude, in presence
of glucose. k Effect of TA (n=9) on the membrane plateau potential
during active phase, in presence of glucose. The experiments were
performed on ten preparations of mice islets. Friedman test on f, P=
0.05; repeated measures ANOVA test on k, P=6.88×10−10. *P<0.05,
***P<0.001 vs. 2.8-mM glucose condition; °°P<0.01, °°°P<0.001 vs.
16.7-mMglucose condition (paired Student’s t tests in c–e, h–j;Wilcoxon
type tests with Dunn–Bonferroni correction in f; least significant
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Fig. 4 Effect of Ano1 inhibitors on the membrane potential of 16.7 mM
glucose-stimulated murine dispersed β-cells. Zero-current nystatin-
perforated patch-clamp voltage recordings performed on dispersed β-
cells stimulated with 16.7 mM glucose before incubation with T-AO1
or TA (100 μM) in the bathing medium. Sampling rate, 18 kHz; 2-kHz
filter setting. Dotted lines represent zero-voltage level. a–f Experiments
carried out on rat dispersed β-cells, n=7 from three preparations of rat
dispersed islet cells in presence of T-AO1 and n=8 from two preparations
of rat dispersed islet cells with TA. a Representative recording±T-AO1.
Effect of T-AO1 b on AP rate and c on average membrane potential. d
Representative recording±TA. Effect of TA e onAP rate and f on average
membrane potential. g–i Experiments carried out on mice dispersed β-
cells, n=4 from one preparation of mice dispersed islet cells. g
Representative recording±T-AO1. Effect of T-AO1 h on AP rate and i
on average membrane potential. Repeated measures ANOVA test on c,
P=0.00123; f, P=2×10−4; Friedman test on i, P=0.18. ***P<0.001 vs.
2.8 mM glucose condition; °°P<0.01, °°°P<0.001 vs. 16.7 mM glucose
condition (least significant difference tests in c, f; paired Student’s t tests
in b, e, h)
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−50.94±4.97 mV, thus by 13.33±2.58 mV (Fig. 4c, n=7, P=
0.00209), while TA did not (Fig. 4f, −34.82±1.65 mV in its
absence, −35.48±5.69 mV in its presence; n=8, P=0.907).
Similar effects were observed in mice β-cells: glucose
(16.7 mM) depolarized the cell from −69.12±2.64 mV (rest-
ing potential at 2.8 mM glucose) to −38.17± 3.46 mV (n=4).
T-AO1 quite potently and significantly reduced AP rate from
3.91±0.38 to 0.48±0.27 s−1, i.e., by 87.4±7.2 % (Fig. 4h, n=
4, P=0,00602). T-AO1 repolarized the cell from −38.17±3.47
to −54.10±4.44 mV, thus by 15.94±5.96 mV, although this
effect did not reach statistical significance threshold (Fig. 4i,
n=4). Interestingly, the washout of T-AO1 inhibitor seemed to
reverse its effects (with restored spiking activity), while the
effect of TA did not show any recovery during the period of
observation (Figs. 3g and 4g).
Chloride currents from rat β-cells (inside-out excised
macropatches and whole cell) display Ano1 properties
Figure 5 shows Cl− current recordings from excised
macropatches and from whole cell performed on rat β-cells.
These currents depend on the number of channels within the
patch and on their open probability. At 0 μMCa2+ with Cl− as
only permeant ion (symmetrical 150 mMNMDG-Cl [78]), no
currents were observed (Fig. 5a on excised patches, Fig. 5n on
whole cell). At 1 μM Ca2+, outwardly rectifying Cl− currents
were observed. The outward currents were composed of a
small instantaneous time-independent component and a large
slowly activating time-dependent component (Fig. 5b on sin-
gle excised patches and 5o on whole cell). At 2 μM Ca2+, the
main component of the current became instantaneous and
time-independent. The inward and outward Cl− currents
reached steady-state quasi-instantaneously and became almost
symmetrical so that the current–voltage relationship became
approximately linear (Fig. 5c, f, g, i on single excised patches).
Thus, in rat β-cells, Cl− currents critically depend on [Ca2+]i
which is a characteristic of CaCCs [22, 39]. The permeability
sequence of monovalent anions, which is also characteristic
by CaCCs, was analyzed in whole-cell experiments replacing
extracellular 150 mM NMDG-Cl by equimolar NMDG-NO3
or NMDG-Br. Pipette solution contained 150 mM NMDG-Cl
and 1 μM Ca2+ (neither cyclic AMP (cAMP) nor ATP). An
agar-KCl 3M salt bridge provided the junction between the
Ag/AgCl reference electrode and the bath. Permeability ratios
(Px/PCl) of nitrate and bromide anions were calculated from
the shifts of the reversal potentials using Goldman, Hodgkin,
and Katz equation. The currents observed were outwardly
rectifying. Replacing NMDG-Cl by NMDG-NO3 increased
the current amplitude at positive potentials and shifted the
reversal potentials toward negative potentials from −0.71±
0.91 to −16.65±1.34 mV (Fig. 5j, k, top, n=11, P=8.33×
10−7), i.e., by −15.94±1.49 mV. Replacing NMDG-Cl by
NMDG-Br had similar effects but shifted the reversal
potentials toward less negative potentials from −0.38±1.09
to −9.66±1.51 mV (Fig. 5l, k, bottom, n=9, P=6.5×10−5),
i.e., by −9.28±1.23mV. The relative permeabilities (Px/PCl) of
these anions were thus NO3
− (1.83±0.10) > Br− (1.42±0.07)
> Cl− (1.0) (Fig. 5m) consistent with the values reported for
endogenous CaCCs and Ano1-transfected cells [22, 39, 78].
We then investigated the effects of blocking Ano1 on the Cl−
currents. In these experiments, pipette and bath solutions
contained 150 mM NMDG-Cl. On inside-out excised
macropatches, 10 μM T-AO1 in the pipette solution preincu-
bated for 5 min abolished 2 μMCa2+-activated Cl− currents at
+100 mV (Fig. 5a, c, e, f; currents at 2 μM Ca2+: 226.10±
47.39 pA, n=8; with T-AO1: 19.73±4.32 pA, n=12, P=0.019
which is not different from current at 0 μM Ca2+: 6.80±
0.94 pA, n=12, P=0.071). Blocking Ano1 antibodies
ab72984 1:100 [14] in the pipette solution (extracellular side
of the patch) preincubated for 4 min totally abolished 2 μM
Ca2+-activated Cl− currents at +100mV compared with boiled
ab72984 1:100 in the pipette (Fig. 5a, g–i; control current at
2 μMCa2+ with boiled antibody: 191.59±17.75 pA, n=18 vs.
with active antibody: 15.44±4.01 pA, n=13, P<0. 001 which
is not different from current at 0 μMCa2+, P>0.999). Whole-
cell current activated by 1 μM Ca2+ in the pipette was simi-
larly strongly inhibited in the presence of 10 μM T-AO1
(bath) for 2 min (Fig. 5n–q; 1 μM Ca2+-activated control
normalized current at +100 mV: 451.93±52.71 pA/pF, n=
21; with T-AO1: 98.78±15.31 pA/pF, n=15, P=0.001). In
whole-cell experiments, ab72984 in the pipette (cytosolic
side) always reduced 1 μM Ca2+-activated Cl− currents at +
100 mV measured at different times (Fig. 5r–t; boiled vs.
active antibody at 6 min: 436.61±29.03 pA/pF, n=14 vs.
194.48±29.03 pA/pF, n=13, P=1.26×10−4; at 8 min:
379.48±34.72 pA/pF, n=12 vs. 147.71±16.01 pA/pF, n=12,
P=4×10−6; at 10min: 258.06±25.37 pA/pF, n=10 vs. 114.82
±10.69 pA/pF, n=10, P=2.15×10−4; at 12 min: 223.33±
45.20 pA/pF, n=5 vs. 101.60±10.05 pA/pF, n=8, P=0.007).
Single-channel Cl− currents from inside-out patches
isolated from rat β-cells are consistent with Ano1 currents
In the absence of Ca2+ in the bathing medium, no current was
observed, while 1 μMCa2+ activated single-channel Cl− current
(filled pipette resistance 20 MΩ). Representative single-channel
Cl− current recordings are shown in Fig. 6a; their amplitude was
calculated byGaussian fit to all-point histograms of recordings at
a sampling rate of 5 kHz (Fig. 6b). The observed amplitudes of
single-channel Cl− currents were small, as also described for
CaCCs by Nilius et al. [49, 50]. The single-channel current–
voltage relationship (which plots the amplitude of one channel
independently of its open probability vs. voltage) was linear (r=
0.989, P<0.0001, Fig. 6c). Its slope, i.e., the single-channel con-
ductance (γ=8.37±0.15 pS), exactly matches the conductance
described for Ano1 in similar conditions in transfected
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Fig. 5 Chloride currents from rat β-cells (inside-out excised
macropatches and whole cell). a–i Chloride currents from inside-out sin-
gle excised patches. Pipette and bath solutions contained 150 mM
NMDG-Cl. Sampling rate, 25 kHz; 2-kHz filter setting. Filled pipette
resistance, 5 MΩ. Current traces recorded were induced by 1500-ms
voltage steps from −100 to +100 mV, spaced 20 mV (holding potential,
−70 mV, 200 ms before and after each step). Dotted lines indicate zero-
current level. a–c Representative recordings of Cl− currents. The
cytosolic face was exposed to bath solutions with different [Ca2+]:
0 μM in a, 1 μM in b, and 2 μM in c. d Steady-state current–voltage
relationships of Cl− currents at 0 μMCa2+ (n=12), 1 μMCa2+ (n=5), and
2 μM Ca2+ (n=8). e Representative recording of Cl− currents stimulated
by 2 μM Ca2+ in the presence of T-AO1 10 μM in the pipette. f Steady-
state current–voltage relationships of Cl− currents at 2 μM Ca2+ in the
absence (n=8) or presence (n=12) of T-AO1 10 μM in the pipette and at
0 μM Ca2+ (n=12). g, h Representative recordings of Cl− currents
stimulated by 2 μM Ca2+, respectively, in the presence of boiled or
active blocking Ano1 antibodies ab72984 1:100 in the pipette. i Steady-
state current–voltage relationships of Cl− currents at 2 μM Ca2+ in the
presence of boiled (n=18) or active (n=13) blocking Ano1 antibodies
ab72984 1:100 in the pipette and at 0 μM Ca2+ (n=12). j–t Whole-cell
Cl− currents from dispersed β-cells. Pipette and bath solutions contained
150 mM NMDG-Cl except in anion selectivity experiments where the
bath Cl− was replaced by NO3
− or Br− for repeated measures. Sampling
rate, 10 or 25 kHz; 2-kHz filter setting. Filled pipette resistance, 5 MΩ.
Dotted lines indicate zero current or Px/PCl=1 level. j, l Representative
current traces from β-cells induced by voltage ramps (20 mV/s) at 1 μM
Ca2+ (pipette). Bath NMDG-Cl solution was replaced by either NMDG-
NO3 in j or NMDG-Br in l. kNitrate and bromide anions shift the reversal
potential (V rev) toward negative values (n=11 and 9, respectively). m
Permeability ratios (Px/PCl) of nitrate and bromide anions calculated from
the shifts of the reversal potentials in k using Goldman, Hodgkin, and
Katz equation. n–t Current traces recorded were induced by 400-ms
voltage steps from −100 to +100 mV, spaced 20 mV (holding potential,
−70 mV, 100 ms before and after each step). n–p Representative
recordings of whole-cell Cl− currents at 0 μM Ca2+ in n, 1 μM in o,
and 1 μM in the presence of T-AO1 10 μM in the bath medium in p. q
Normalized current–voltage relationships of whole-cell Cl− currents at
1 μM Ca2+ in the absence (n=21) or presence (n=15) of T-AO1 10 μM
in the bath medium and at 0 μM Ca2+ (n=14). r, s Representative
recordings of whole-cell Cl− currents evoked by 1 μM Ca2+ at +
100 mV after 6-, 8-, and 10-min membrane rupture in the presence of
boiled Ano1 antibodies ab72984 1:100 in the pipette (r) or active Ano1
antibodies ab72984 1:100 in the pipette (s). t Normalized whole-cell Cl−
currents evoked by 1 μMCa2+ at the end of the +100-mV voltage step in
the presence of boiled Ano1 antibodies ab72984 1:100 or active Ano1
antibodies ab72984 1:100 in the pipette after 6 min (n=14 and 13), 8 min
(n=12 and 12), 10 min (n=10 and 10), and 12 min (n=5 and 8)
membrane rupture. Experiments of Fig. 5 were carried out on six
preparations of rat dispersed islet cells. Kruskal–Wallis tests on f, i, q,
P<0.001, *P<0.05, **P<0.01, ***P<0.001 vs. control (Mann–
Whitney-type tests with Dunn–Bonferroni correction in f, i, q, paired
Student’s t tests in k, independent Student’s t tests in t)
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Ano1/ETAR-HEK 293 cells [78]. The channel open probability
was more important at positive voltages and decreased toward
negative potentials, a well-known characteristic of CaCCs [49,
50], as confirmed by outwardly rectifyingwhole-cell and excised
macropatch Cl− currents activated by 1 μM Ca2+ (Fig. 5b, o).
The effect of the inhibitors T-AO1 andTA, considered as specific
for Ano1 [47, 48], was evaluated by measuring their effect on
NPo at +60 mV (Fig. 6d). The inhibitors were added in the
pipette solution before sealing. NPo was calculated for 2 min
after 15-s stimulation with 1 μMCa2+. For control patches, NPo
was 2.55±0.28 (n=5). In presence of T-AO1, no opening was
observed (n=7, P<0.001), and with TA, NPo drastically de-
creased to 0.36±0.23 (n=6, P=0.0041). The abolishment of
single-channel Cl− current attests that Ano1 is indeed the target
affected by these inhibitors. Recordings were validated only
when patches showed one or a few single-channel events at
the beginning of the measurements (immediately after excision,
i.e., shortly after NaCl medium containing 1-mM Ca2+ replace-
ment) or at + 100 mVat the end of recordings.
Effect of Ano1 inhibitors on whole-cell Ba2+ currents
from rat dispersed β-cells
Although the current evidence points to a specific effect on Cl−
channels, it could still be argued that these inhibitors directly
affect also the opening of L-type Ca2+ channels. Whole-cell
Ba2+ current is representative of Ca2+ current mediated by L-
type Ca2+ channels. Ba2+ currents were recorded during 200-
ms depolarizations to −10 mV from a holding potential of
−70 mV in the presence (or not) of T-AO1, TA, or nifedipine
in the bathing medium (Fig. 7a). Note that a rundown of the
currents occurred after a few stimulations [2]. Nifedipine largely
inhibited the current (Fig. 7a, b). The appearance of the current
(I)–voltage (V) relationship (Fig. 7c) together with the nifedipine
inhibition thereby confirms the implication of L-type Ca2+ chan-
nels asmediators of these Ba2+ currents [2, 59, 60, 77]. Figure 7b
summarizes the normalized whole-cell peak inward Ba2+ cur-
rents observed in the same conditions as in Fig. 7a. Control value
averaged −35.60±3.49 pA/pF (n=27). Neither T-AO1 nor TA
had any inhibitory effect on the Ba2+ current: T-AO1-exposed
cells exhibited average current values of −40.84±6.09 pA/pF
(n=17 cells, P>0.5), and cells perfused in presence of TA,
−39.21±6.51 pA/pF (n=16, P>0.5). Nifedipine quite potently
and significantly reduced the current to 27.7±3.9 % of the aver-
age control value, i.e., −9.85±1.37 pA/pF (n=17, P<0.001).
The average cell capacitance was 7.66±0.35 pF (n=77).
Effect of reduced intracellular Cl− and HCO3
−
on membrane potential oscillations in dispersed β-cells
The last series of experiments aimed at investigating the pos-
sible role of Ano1 in the exit of bicarbonate anions from islet
cells. To reduce intracellular Cl− and HCO3
−, we used here an
incubation medium containing no HCO3
− and low Cl− con-
centration (20 mM) with bumetanide (200 μM), the latter
preventing Cl− recycling through the Na+–K+–2 Cl−-


















































Fig. 6 Single-channel Cl− currents from inside-out patches excised from
rat β-cells. Pipette and bath solutions contained 150 mM NMDG-Cl;
pipette contained also 10 μM nifedipine and 10 μM glibenclamide.
Sampling rate, 5 kHz; 1-kHz filter setting; 100-Hz final digital
filtration. Filled pipette resistance, 20 MΩ. Dotted lines indicate zero-
current or single-channel levels. a Representative recordings. Single-
channel currents are activated by 1 μM Ca2+ in the bathing solution. b
Representative number of events–amplitude histograms at +60 and +
80 mV. Single-channel amplitudes were obtained from Gaussian fit.
The scale bars indicate 250 events. c Current–voltage relationship of
single-channel Cl− currents activated by Ca2+. A single-channel
conductance (γ) of 8.37±0.15 pS was calculated from a linear fit (r=
0,989, P<0.0001) on all the points (n=65: +100 mV, n=6; +80 mV, n=
7; +60 mV, n=28; +40 mV, n=7; −40 mV, n=3; −60 mV, n=6; −80 mV,
n=5; −100 mV, n=3 experiments performed on six preparations of rat
dispersed islet cells). d Time course of channel activity before and during
exposure to 1 μMCa2+ in the absence of inhibitors (n=5), in the presence
of T-AO1 100 μM (n=7) and in the presence of TA 100 μM (n=6) in the
pipette solution at +60 mV. Upper panel: representative recordings in
presence (or not) of the inhibitors. Lower panel: mean NPo (±SEM)
values, i.e., the product of the number of channels in a patch (N) by the
open probability (Po), calculated for 2 min, after 15-s stimulation with
Ca2+. The n experiments were performed on two preparations of rat
dispersed islet cells. Kruskal–Wallis test on d, P<0.001, *P<0.05,
***P<0.001 vs. control (Mann–Whitney-type tests with Dunn–
Bonferroni correction)
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cotransporters NKCC1/2 [1]. The addition of 16.7 mM glu-
cose (Fig. 8a, b) elicited spiking activity whose AP amplitude
reduced within 1 min from 42.17±3.16 to 27.62±1.37 mV;
Δ=14.55±2.96 mV (Fig. 8c, n=6, P=0.00441). Concomi-
tantly, AP peak repolarized from −5.58±5.02 to −17.28±
4.59 mV; Δ=11.70±1.90 mV (Fig. 8d, n=6, P=0.00163).
The latter parameters were further reduced upon addition of
5 mM acetazolamide: AP amplitude was decreased to 14.10±
1.80 mV, i.e., to 35.2±6.1 % of the initial value (Fig. 8c, n=6,
P=0.00123). AP peak repolarized to −20.45±4.28 mV
(Fig. 8d, n=6, P=0.00192). The resting potential averaged
−65.29±3.14 mV. During the first minute of spiking activity,
the membrane voltage averaged −29.10±4.04 mV (Fig. 8e,
P=2.92×10−4). The subsequent reductions in AP peak and
amplitude observed including in the presence of acetazol-
amide did not significantly affect the average membrane
potential.
Discussion
The β-cell is an excitable cell in which raising glucose con-
centration above a threshold value of 5.5–6 mM induces a
characteristic fluctuating electrical activity. This cyclic pattern
alternates repetitive phases of depolarized plateau potential
(slow waves) on top of which Ca2+-dependent AP superim-
poses (Bactive phase^) with partially repolarized silent phases
[15–17, 31]. Variations in membrane potential are instrumen-
tal in inducing Ca2+ variations [5, 59, 61], hence insulin re-
lease. Importantly, insulin release is sustained only when these
membrane potential fluctuations are also sustained [7, 24, 30].
Glucose also induces an increase in 36Cl− efflux from mice
islet β-cells. Severe reduction in this efflux by incubation in
low Cl−media inhibited the electrical bursting pattern together
with the 45Ca2+ uptake and, therefore, the glucose-stimulated
insulin secretion [65, 67]. This glucose-induced Cl− efflux
from rat pancreatic islet β-cells increases in proportion to
the extracellular glucose concentration in the range of 6 to
20 mM [43].
The present experiments were undertaken to find out
whether the observed Cl− and possibly HCO3
− efflux from
rat pancreatic islet β-cells are mediated by Ano1. As a first
approach, we demonstrated the expression of Ano1 in rat pan-
creatic islet β-cells by RT-PCR (including sequence analysis),
immunohistochemistry (including inhibition of labeling by
Ano1 synthetic peptide), and western blotting (Fig. 1). Of
interest, transcripts of the expected size of Ano1 were also
found in preparations from human pancreatic tissue, thus

























































Fig. 7 Whole-cell Ba++ currents from rat dispersed β-cells. The bathing
solution contained the following (in mM): 75 BaCl2, 10 Hepes, 35
NMDG-gluconate (pH 7.3 with NMDG, osmolarity 310 mOsm/l) in
presence (or not) of T-AO1 (100 μM), TA (100 μM), or nifedipine
(10 μM). Pipette solution contained the following (in mM): 103
NMDG-Cl , 10 Hepes, 3 MgATP, 43 NMDG-gluconate, and 10−4
CaGluconate2 (pH 7.15 with NMDG, osmolarity 310 mOsm/l).
Sampling rate, 5 kHz; 1-kHz filter setting. a Representative whole-cell
currents being observed during 200-ms depolarization to −10 mV from a
holding potential of −70 mV in the presence (or not) of T-AO1, TA, or
nifedipine (NIFE) in the bathing medium. b Summary of normalized
whole-cell peak Ba2+ currents observed with the same protocol as in a.
For control experiments, n=27.While T-AO1 (n=17) and TA (n=16) had
no effect on the Ba2+ current, nifedipine potently reduced it (n=17). c
Normalized whole-cell peak inward Ba2+ current–voltage relation
observed during 25-ms depolarization. Voltage steps were applied from
a holding potential of −70mV, n=6. The current values were corrected for
leakage and capacity currents. Experiments of these sets were carried out
on two preparations of rat dispersed islet cells. Kruskal–Wallis test on b,
P<0.001, ***P<0.001 vs. control (Mann–Whitney-type tests with
Dunn–Bonferroni correction)
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suggesting that Ano1 is also expressed in human. As a second
approach, wemeasured the effect of Ano1 inhibitors on GSIS.
Exposure to 100 μM T-AO1 totally prevented the increment
of insulin secretion induced by 8.3 and 16.7 mM glucose;
exposure to TA was qualitatively similar with a complete in-
hibition at 8.3 mM glucose but not total (67 %) at 16.7 mM
glucose. The concentration of inhibitors necessary to abolish
GSIS was admittedly rather high, but this is probably merely
related to diffusion into the center of islet where β-cells reside
[33]. We therefore also looked at the effect of the blocking
Ano1 antibodies ab72984 [14] which at 1:100 abolished
16.7 mM GSIS (Fig. 2 (c3)).
In β-cell, glucose induces a typical pattern of cyclic fluc-
tuations of the membrane potential. Yet, while the rhythmic
electrical activity of the heart evidenced in the electrocardio-
gram can be adequated to the gating of a series of well-
identified ionic channels [4], only a few channels have been
well identified as critically involved and necessary for the
glucose-induced fluctuations of the β-cell membrane poten-
tial. Glucose is absolutely necessary to induce these cyclic
fluctuations as, when present below its threshold, the mem-
brane potential remains quite stable at around −70 mV. Three
main phases can be individualized: (1) a slow depolarization
ascribed to the closure of KATP channels reproduced by sulfo-
nylurea drugs and inhibited by diazoxide, (2) cyclic waves of
depolarization interrupted by silent phases of partial repolari-
zation whose length decreases when glucose concentration
raises, and (3) AP ascribed to the opening of L-type Ca2+
channels, inhibited by nifedipine. The last two phases are
reminiscent of the pacing activity of interstitial cells of Cajal
in the intestine [35, 79] except that glucose is absolutely re-
quired to induce this pacing activity in β-cell. A third objec-
tive of this study was to show that Ano1 mediates the cyclic
waves of depolarization, which are absolutely necessary to
reach the threshold of the L-type Ca2+ channels (triggering
AP). These waves of depolarization can be at least partially
attributed to the gating of Ano1 (with Cl− exit from theβ-cell),
as exposure to T-AO1 or TA inhibitors almost totally sup-
pressed AP or at least drastically reduced AP rate. The more
potent T-AO1 partially repolarized the β-cell (Figs. 3 and 4).
Drastic reduction in AP rate severely impairs insulin secretion
(Figs. 2, 3, and 4). Furthermore, the inhibitors repolarized the
AP peak which also plays a role in Ca2+ influx. Finally, TA
reduced by one-third AP amplitude in mice β-cells from
whole islet upon 16.7-mM glucose stimulation, while nomore
AP was observed in rat dispersed β-cells. A contrario, in-
creased AP rate is known to raise Ca2+i and insulin secretion
by SK4−/− mice [19]. Increased AP amplitude (with increased
AP peak) observed by blocking large-conductance Ca2+-acti-
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Fig. 8 Effect of glucose on membrane potential oscillations in single rat
β-cells exposed to low Cl−/HCO3
−-free medium. Zero-current nystatin-
perforated patch-clamp voltage recordings. Sampling rate, 18 kHz; 2-kHz
filter setting. Dotted lines represent zero-voltage level. β-Cells were
continuously exposed to 200 μM bumetanide (Bum), a NKCC1/2
inhibitor, and stimulated with 16.7 mM glucose (G 16.7 mM) in Hepes-
buffered NaCl solution without bicarbonate containing 20 mMCl−. After
10-min glucose stimulation, 5 mM acetazolamide (Acet), a carbonic
anhydrase inhibitor, was added to further reduce intracellular HCO3
−. a
Representative recording. b Extended timescale of recording a. c AP
amplitude at various times, i.e., at the beginning of the spiking activity
before rundown (Ini), after 5 min in presence of glucose stimulation (G +
5min), and after 5 min in presence of acetazolamide (Acet + 5 min). dAP
peak voltage at similar times. e Mean voltage at similar times. For all
results, n=6 experiments performed on one preparation of rat islets.
Repeated measures ANOVA test on c, P=2.50×10−5; d, P=1.29×10−4;
and e, P=7.42×10−10. **P<0.01, ***P<0.001 vs. 2.8-mM glucose
condition in presence of bumetanide; °P<0.05, °°P<0.01 vs. Ini;
##P<0.01 vs. G + 5 min (Sidak tests)
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increased Ca2+ entry and insulin secretion [34], while reduc-
tion in AP amplitude by tetrodotoxin drastically reduced the
stimulation of insulin secretion in human β-cells [10].
The presence of active Ano1 channels in β-cells was dem-
onstrated in inside-out excised patches and in conventional
whole-cell patch-clamp experiments on dispersed cells. Chlo-
ride currents from rat β-cells display typical properties of
CaCCs (Fig. 5). No Cl− current was observed in the absence
of intracellular Ca2+ (symmetrical 150 mM NMDG-Cl condi-
tion in the absence of cAMP and ATP). One-micromolar Ca2+
directly triggered strongly outwardly rectifying currents show-
ing a large slowly activating time-dependent component, and
this behavior completely changed to nearly linear at 2 μM
[Ca2+]i with a large instantaneous, time-independent compo-
nent. This different behavior depending on [Ca2+]i is charac-
teristic by CaCCs [22, 39] now identified as Ano1 [64]. The
permeability sequence of monovalent anions, which is also
characteristic by CaCCs, was analyzed in whole-cell experi-
ments (1 μM [Ca2+]i) replacing extracellular 150 mM
NMDG-Cl by equimolar NMDG-NO3 or NMDG-Br. Perme-
ability ratios (Px/PCl) of nitrate and bromide anions calculated
from the shifts of the reversal potentials using Goldman,
Hodgkin, and Katz equation were NO3
− (1.83±0.10) > Br−
(1.42±0.07) > Cl− (1.0), consistent with those reported for
endogenous CaCCs and Ano1-transfected cells [22, 39, 78].
The observed currents were outwardly rectifying, excluding
cystic fibrosis transmembrane conductance Regulator (CFTR)
currents. Furthermore, blocking Ano1 antibodies ab72984
[14] directed against the fifth and sixth transmembrane do-
mains that constitute the pore-forming region and T-AO1 used
at 10 μM here directly in contact with the cell membrane
completely abolished the 2 μM Ca2+-activated Cl− currents
from inside-out excised macropatches from rat β-cell. A sim-
ilar inhibitory effect of T-AO1 on 1 μM Ca2+-activated Cl−
currents was observed in whole-cell experiments. These ob-
servations prove that active Ano1 channels are present in the
β-cell membrane. Finally, single-channel Cl− currents were
examined in inside-out excised patches from rat β-cell mem-
brane (Fig. 6). The activation of the channels was Ca2+-de-
pendent, as in the absence of Ca2+ in the bath (cytoplasmic
side), no current was observed. At 1 μM Ca2+, a unique Cl−
conductance was evoked. The channel involved exhibited a
linear I/V relationship, with a small slope conductance of 8.37
±0.15 pS matching the Ano1 conductance reported under
similar conditions (symmetrical 150 mM NMDG-Cl) [55,
78]. Its opening (measured by NPo) was abolished in the
presence of Ano1 inhibitors (T-AO1 or TA) [47, 48]. Again,
these single-channel experiments were performed in absence
of ATP, PKA, and cAMP and channel activation required
Ca2+, excluding CFTR [11, 20] under these conditions al-
though it has a nearly similar conductance (10 pS).
L-type Ca2+ channels were not affected byAno1 inhibitors,
as shown by the whole-cell Ba2+current experiments (Fig. 7),
thus ruling out unspecific effect of the inhibitors on Ca2+
channels.
Interestingly, the direct cause of Ano1 opening is still in
debate. Potential candidates are (i) an increase in intracellular
Ca2+, an enhanced Ano1-Ca2+ sensitivity induced by plasma
membrane depolarization, or still Ca2+–calmodulin depen-
dence; the Ca2+ increase could be very localized in microdo-
mains of excluded cytoplasmic volume and defined by the
close association between restricted plasma membrane do-
main and the endoplasmic reticulum (ER) [36, 73], as Ano1
seems to tether the plasma membrane to the ER as shown in
the interstitial cells of Cajal [80]; (ii) an ATP-dependent mech-
anism (as for example, phosphorylation, dephosphorylation)
[55] or an unknown dependence on cytosolic ATP [73]; (iii) a
dependence of Ano1 opening from the CFTR as Edlund et al.
[21] suggested a direct interaction between Ano1 and the
CFTR when the latter is open by the cAMP/PKA pathway.
However, the expression level of Ano1 is far greater than that
of the CFTR. Also, their experiments were all performed in
the presence of forskolin or GLP-1, which was not the case in
the present study. Finally, these authors hypothesized that
CFTR/Ano1 mediates a Cl− influx during AP, i.e., when the
Cl− electrochemical potential favors Cl− into the cytosol and
eventually into the granules (via ClC-3 channel). In another
setting, Kunzelmann and Mehta [37] also suggested that the
CFTR may play a role in Ano1 opening. Although the link
between CFTR and Ano1 remains to be defined, this sugges-
tion is quite interesting as another recent study strongly impli-
cated the CFTR chloride channel in the glucose-induced β-
cell plasma membrane depolarization [26]. Thus, besides
Ano1, the CFTR may also participate to the Cl− efflux current
upon glucose stimulation as the latter increases cAMP produc-
tion [58]. However, diabetes observed in cystic fibrosis is
rather uncommon before the first decade [46], suggesting that
CFTR is not of absolute necessity for GSIS but could repre-
sent a way to open Ano1 under some physiological condi-
tions. Clearly, the question of how glucose triggers Ano1
opening is not solved, and among attractive useful candidates,
some of the numerous TRP channels expressed in the rat β-
cell [13] could also be raised as they depolarize the cell and
often mediate Ca2+ influx. For instance, an increment of reac-
tive oxygen species (ROS) production, as observed upon
16.7-mM glucose stimulation of mouse or rat β-cells islets
[41, 57], activated TRPM2 and increased [Ca2+]i in INS-1E
and human β-cells [3]. Furthermore, insulin secretion was
impaired in TRPM2−/− mice [74]. In addition, a decrease in
glucose-induced Ca2+ oscillations responsible for a drastic
reduction in insulin secretion was described in TRPM5−/−
mice [12].
As a final objective, we examined whether HCO3
− can also
exit through Ano1. Bicarbonate ion appears to play a role in
insulin secretion as (1) its omission from the extracellular
medium drastically reduces insulin secretion [29]; (2) its entry
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into the β-cell appears mediated by NBCe1-B [27, 53]. This
electrogenic Na+–HCO3
−-cotransporter, expressed in rat and
human islet β-cells [27, 71], carries the entry of one negative
charge (stoichiometry: 1 Na+/2 HCO3
−). Thus, HCO3
− entry is
facilitated when the cell depolarizes and also when cytoplas-
mic Cl− decreases, given that NBCe1-B has Cl−-binding mo-
tifs [69]; (3) its concentration depends on its production from
glucose metabolism which generates H2O and CO2, partially
converted into HCO3
− and H+ ions in the presence of mito-
chondrial type V carbonic anhydrase [68]. While the protons
can probably recycle into the mitochondrial matrix or rapidly
exit the β-cell through the sodium–proton exchanger NHE1,
HCO3
− first accumulates within the cytoplasm; hence, it con-
tributes to its alkalinization [18, 72] and possibly to cell vol-
ume increase. Acetazolamide-induced inhibition of carbonic
anhydrase also decreases insulin secretion in rat pancreatic
islets [54, 68]. Thus, upon glucose stimulation, intracellular
HCO3
− appears to increase from two different sources: meta-
bolically generated from mitochondrial pyruvate oxidation
and absorbed from the extracellular medium through
NBCe1-B. When cytoplasmic Cl− is largely decreased as a
result of its exit through Ano1, HCO3
− which has been accu-
mulated within the cytoplasm can also exit through Ano1, as
this channel has been shown to be permeant to HCO3
− [55].
When intracellular Cl− was decreased, in the presence of bu-
metanide and 16.7 mM glucose, AP amplitude was reduced
with repolarized AP peak. In these conditions, bumetanide
prevented Cl− recycling; hence, Ano1 current mediated the
exit of HCO3
−. Acetazolamide which partially reduces intra-
cellular HCO3
− concentration decreased further AP amplitude
and peak, in HCO3
−-free media (Fig. 8). As shown by Sener
et al. [68], acetazolamide also decreased GSIS in rat islets.
Thus, glucose also appears to induce HCO3
− exit through
Ano1.
Ano1−/− mice do not survive more than a few days unlike
Ano1+/− mice which showed impaired insulin secretion [76].
This elegant study also completely supports a role for Ano1 in
insulin secretion. The authors reported that insulin and Ano1
genes lie on the same human chromosome 11, that they inter-
act with each other, and that this interaction is strengthened,
upon glucose stimulation. Twenty-five-millimolar glucose in-
duced a threefold increased expression of Ano1 after 1 h,
whereas its expression was decreased in the presence of
siRNA against the insulin promoter.
Thus, the glucose-induced gating of Ano1 may be as im-
portant as the K+ATP channel closure to induce β-cell depolar-
ization. We further suggest that Ano1 cyclic gating is respon-
sible for the oscillatory pattern of membrane potential upon
glucose stimulation with alternating active phases with AP
and partially repolarized silent phases. These are instrumental
in generating Ca2+i oscillations and sustained insulin secre-
tion. Blocking Ano1 nearly completely abolished the mem-
brane potential oscillations as well as GSIS.
In conclusion, the present results demonstrate that in mu-
rine β-cells, glucose-induced opening of Ano1 is absolutely
critical to reach the threshold potential for opening the L-type
Ca2+ channels.
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